BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23295800)

  • 1. Angioedema in a patient with renal cell cancer treated with everolimus in combination with an angiotensin-converting enzyme inhibitor.
    Rothermundt C; Gillessen S
    J Clin Oncol; 2013 Feb; 31(5):e57-8. PubMed ID: 23295800
    [No Abstract]   [Full Text] [Related]  

  • 2. Lingual angioedema associated with everolimus.
    Mackenzie M; Wood LA
    Acta Oncol; 2010; 49(1):107-9. PubMed ID: 20100146
    [No Abstract]   [Full Text] [Related]  

  • 3. Everolimus: a new mammalian target of rapamycin inhibitor for the treatment of advanced renal cell carcinoma.
    Grgic T; Mis L; Hammond JM
    Ann Pharmacother; 2011 Jan; 45(1):78-83. PubMed ID: 21177421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Piller LB; Ford CE; Davis BR; Nwachuku C; Black HR; Oparil S; Retta TM; Probstfield JL;
    J Clin Hypertens (Greenwich); 2006 Sep; 8(9):649-56; quiz 657-8. PubMed ID: 16957427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: successful treatment with icatibant.
    Charmillon A; Deibener J; Kaminsky P; Louis G
    Intensive Care Med; 2014 Jun; 40(6):893-4. PubMed ID: 24737261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Angioedema of the mucous membranes of the upper aerodigestive tract after administration of ACE inhibitors].
    Tisch M; Maier H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Feb; 32(2):122-3. PubMed ID: 9172718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists].
    de Paz S; Martín AB; Iglesias A; Domínguez AR
    Med Clin (Barc); 1999 Dec; 113(19):759. PubMed ID: 10680137
    [No Abstract]   [Full Text] [Related]  

  • 8. Omission of drug dose information.
    Hollenberg NK
    Arch Intern Med; 2006 Feb; 166(3):368; author reply 368-9. PubMed ID: 16476880
    [No Abstract]   [Full Text] [Related]  

  • 9. Timing isn't everything: A case of recurrent angio-oedema.
    Pham A; Hariri S; Yusin J
    Allergol Immunopathol (Madr); 2015; 43(2):230-1. PubMed ID: 24948189
    [No Abstract]   [Full Text] [Related]  

  • 10. Pneumocystis jirovecii pneumonia in everolimus-treated renal cell carcinoma.
    Loron MC; Grange S; Guerrot D; Di Fiore F; Freguin C; Hanoy M; Le Roy F; Poussard G; Etienne I; Legallicier B; Pfister C; Godin M; Bertrand D
    J Clin Oncol; 2015 Mar; 33(8):e45-7. PubMed ID: 24638002
    [No Abstract]   [Full Text] [Related]  

  • 11. Temsirolimus (Torisel) for advanced renal cell carcinoma.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):103-4. PubMed ID: 18084154
    [No Abstract]   [Full Text] [Related]  

  • 12. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
    Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M
    Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioedema: case report.
    Zallen RD; Raposo V
    J Colo Dent Assoc; 2000; 79(1):26-7. PubMed ID: 11404852
    [No Abstract]   [Full Text] [Related]  

  • 14. Everolimus- and temsirolimus-associated enteritis: report of three cases.
    Parithivel K; Ramaiya N; Jagannathan JP; O'Regan K; Krajewski K; Fisher D; Choueiri TK; Jacobsen E
    J Clin Oncol; 2011 May; 29(14):e404-6. PubMed ID: 21357780
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraoperative angioedema induced by angiotensin-converting enzyme inhibitors: overview and case report.
    O'Ryan F; Poor DB; Hattori M
    J Oral Maxillofac Surg; 2005 Apr; 63(4):551-6. PubMed ID: 15789330
    [No Abstract]   [Full Text] [Related]  

  • 16. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
    Gallitelli M; Alzetta M
    Am J Emerg Med; 2012 Oct; 30(8):1664.e1-2. PubMed ID: 22100478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma.
    Harzstark AL; Small EJ; Weinberg VK; Sun J; Ryan CJ; Lin AM; Fong L; Brocks DR; Rosenberg JE
    Cancer; 2011 Sep; 117(18):4194-200. PubMed ID: 21387258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy.
    Korniyenko A; Alviar CL; Cordova JP; Messerli FH
    Cleve Clin J Med; 2011 May; 78(5):297-304. PubMed ID: 21536824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral angioedema secondary to ACE inhibitors, a frequently overlooked association: case report and review.
    Hurst M; Empson M
    N Z Med J; 2006 Apr; 119(1232):U1930. PubMed ID: 16633389
    [No Abstract]   [Full Text] [Related]  

  • 20. Metastatic renal cell carcinoma: role of mammalian target of rapamycin inhibitors.
    Bukowski RM
    Clin Genitourin Cancer; 2007 Sep; 5(6):359-61. PubMed ID: 17956708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.